Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Urinary Bladder Matrix (UBM) Registry

← catalyst calendar

NCT07805798 · readout in 1,091 d

Sponsored by Integra LifeSciences Corporation (industry) · IART — their whole pipeline →.

Phase
Status
Not yet recruiting
Study type
Observational
Enrollment
300estimated

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-09-04

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2026-08-31estimatedWhen the study began enrolling
Primary completion2029-08-31estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completion2029-12-31estimatedThe whole study's end, after follow-up
First posted2026-09-04actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-09-04actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Tissue Repair
  • Soft Tissue Reconstruction
  • Wound Management
  • Pressure Ulcer (PU)
  • Necrotizing Soft Tissue Infection
  • Fournier's Gangrene
  • Pilonidal Cyst
  • Open Abdomen
  • Hidradenitis Suppurativa (HS)
  • Lower Extremity Wound
  • Incisional

Intervention

  • Device: Urinary Bladder Matrix (UBM) Products

Primary outcome

what the primary-completion date above is the date OF
Incidence of Complete Wound Closure
measured Up to 12 months following the initial UBM application.

Permalink · IART's whole pipeline · Catalyst calendar · Every registered study · What changed